Sesen Bio (SESN) Tops Q1 EPS by 40c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. AXP
6. T
7. TMUS
8. CVS
9. UNH
10. SPY

Go back to Sesen Bio (SESN) Tops Q1 EPS by 40c

Sesen Bio Reports First Quarter 2020 Financial Results and Meaningful Progress Towards Demonstrating Analytical Comparability

May 11, 2020 7:00 AM EDT

Manufacturing and release testing of the Fujifilm pre-PPQ batch completed successfully

Positive Interactions with EMA on Regulatory Pathway for Vicinium® in Europe

Market research conducted in 1Q 2020 supports Urologists prefer Vicinium to Keytruda®

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported operating results for the first quarter ended March 31, 2020. The Company also provided an update on the progress of manufacturing activities... More